Cell Therapeutics Inc. (CTIC) Reports In-Line Q4 Loss of $0.20/Sh

February 28, 2013 5:35 PM EST Send to a Friend
Get Alerts CTIC Hot Sheet
Price: $2.39 -1.65%

Financial Fact:
Noncontrolling interest: 80K

Today's EPS Names:
SGMS, EDE, WSTG, More
Trade CTIC Now!
Join SI Premium – FREE
Cell Therapeutics Inc. (NASDAQ: CTIC) reported Q4 EPS of ($0.20), in-line with the analyst estimate of ($0.20).

For 2013, loss from operations is expected to be approximately $60 to $65 million, excluding non-cash stock-based compensation expense.

For earnings history and earnings-related data on Cell Therapeutics Inc. (CTIC) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment